Abstract

This work discusses the manner in which the public has dealt with the ethical questions about human embryonic stem cell research. It argues that the public is not a homogenous entity, but rather consists of a number of "different publics", which at different points of the debate have discussed different aspects and different questions of this therapeutic proposal. It understands the development of human stem cell therapy not as a result of the activity of an isolated science, acting independently of society. In the contrary it considers it as a co-production of science with the different social actors, which participate in the political, ethical, and legal processes. Therefore the question if ethics is ahead or lags behind the developments in medical research becomes obsolete. Ethics is on one side the result of the effort to handle the results of biomedical research in a manner which is adequate for society at large on the other side it also influences the scientific-technological development through its own assessment.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call